- ASSISTANT PROFESSOR Surgery
Study on Etiology of Thyroid Carcinoma in Iodine Deficient Areas
The Institute of Science and Technology, Jilin Province, China
Comparative Study of Portal-systemic Shunting Rate Measured By the Formula and Radioactive Methods
1996, 1998 -
Third Clinical Hospital, Norman Bethune University of Medical Sciences
Liver Carcinoma Association, Changchu City
Outstanding Scientific and Technical Outcome of China during 1990-1995
Longmen Publishing House of Chinese Academy of Science
Second Prize (No. 94062058)
Chinese Academy of Sciences
Pressure Topography of the Portal Vein System and its Clinical Implications
Scientific and Technical Association of Changchun City
Development and Uses of Micro computerized 4-Channel Physiopressometer
Hui S, Liu J, Zhang D. Effect of treatment with thyroid hormone on thyroid function after radical operation. J N Bethune Med Sci 1995; 21(6): 615-616.
Liu J, Sun H, Li D. Study of portal hemodynamics during the operation. Jilin Medical Journal 1996; 17: 71-72.
Liu J, Sun H, Zhang D. Research of portal hemodynamics with Wheatstone model. J N Bethune Univ Med Sci 1996; 22(4): 446.
Liu J, Sun H, Zhang D. The new design of improving DSRS. J N Bethune Univ Med Sci 1996; 22(4): 447.
Sun H, Liu J, Zhang D. The clinical analysis of nodular goiter associated with thyroid carcinoma. Chinese Journal of Control of Endemic Diseases 1996; 11(4): 230-231.
Sun H, Liu J, Zhang D. Examination of FCM to primary and recurrent thyroid carcinoma and its clinical significance. Jilin Medical Journal 1996; 17(3): 134-135.
Liu J, Sun H, Zhang X. The alteration of portosystemic shunting rate after portosystemic disconnection. Chinese Journal of Clinical Hepatology 1997; 13(3): 140-142.
Zhang D, Liu J, Sun H. Model of proliferation and carcinoma of goiter in iodine deficient areas. Journal of Jiamusi Medical College 1997; 20(5): 29-31.
Liu J, Zhang X, Sun H. Study on portal hemodynamics during the portoazygous disconnection. Chinese Journal of general Surgery 1997; 12(6): 350-352.
Meng X, Liu J, Meng G. Diagnosis and treatment of pancreatic trauma. Chinese Journal of General Surgery 1998; 13(6): 344-345.
Liu J, Zhang X, Meng X. Comparative study on portal-systemic shunting rate measured by the formula and the radioactive methods. Chinese Journal of General Surgery 1998; 36(6): 345-347.
Cao Y, Liu J, Feng G. Experimental study of effects of Octreotide on portal pressure. Railway Medical Journal 1998; 26(1): 10-13.
Zhang X, Liu J, Meng X. Clinical Study on the hemodynamic changes of portal hypertension. Chinese Journal of General Surgery 1998; 13(2): 88-90.
Liu J, Cao Y, Wang C. The experimental study on the mechanism of portal pressure decline induced by Somatostatin. Chinese Journal of General Surgery 1999; 14(3): 230-231.
Wang L, Boros P, Liu J, Qin L, Bai Y, Bielinska AU, Kukowska-Latallo JF, Baker Jr JR, Bromberg JS. DNA/Dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo. Mol Ther 2000 Dec; 2(6): 602-608.
Wang L, Roayaie S, Basile J, Florman S, Liu J, Tarcsafalvi A, Boros P, Miller CM. Graft function and survival depend primarily on host factors in compromised recipient models of orthotopic liver transplantation in the rat. Transplantation 2001; 71(1): 14-20.
Boros P, Tarcsafalvi A, Wang L, Megyesi J, Liu J, Miller CM. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001; 72(5): 805-811.
Bai Y, Liu J, Wang Y, Honig S, Qin L, Boros P, Bromberg JS. L-Selectin-Dependent Lymphoid Occupancy Is Required to Induce Alloantigen-Specific Tolerance. J Immunol 2002; 168: 1579-1589.
Fishbein TM, Wang L, Benjamin C, Liu J, Tarcsafalvi A, Leytin A, Miller CM, Boros P. Successful tolerance induction under CD40 ligation in a rodent small bowel transplant model: first report of a study with the novel antibody AH.F5. Transplantation 2002 Jun 27; 73(12): 1943-1948.
Genden EM, Boros P, Liu J, Bromberg JS, Mayer L. Orthotopic tracheal transplantation in the murine model. J Immunol 2002 May 15; 73(9): 1420-1425.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Liu did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
19 East 98th Street Floor 6 Room 6D
New York, NY 10029